Comparison of requirements on clinical research by FDA on botanical drugs and by China on material medica and naturally occurring drugs
SONG Cai-mei
Machine-generated Keywords：
Publication Date：2020-07-31
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：4( 1587-1590 )